Developed by 149 experts in the field, The International Consensus Classification of Myeloid and Lymphoid Neoplasms provides key information for use at the microscope to assist in arriving at a swift and accurate diagnosis. Drs. Daniel Arber, Michael J. Borowitz, James Cook, Laurence de Leval, John Goodlad, Robert Hasserjian, Rebecca L. King, Hans-Michael Kvasnicka, and Attilio Orazi lead a team of authors who focus on diagnostic criteria and the clinical significance of each disease entity.
1. Introduction to the International Consensus Classification of Myeloid Disorders and Acute Leukemias - p. 1 2. SECTION 1 Myeloproliferative Neoplasms - p. 21 3. 1 Chronic Myeloid Leukemia - p. 22 4. 2 BCR::ABL1-Negative Myeloproliferative Neoplasms - p. 31 5. 3 Chronic Neutrophilic Leukemia - p. 52 6. 4 Chronic Eosinophilic Leukemia, Not Otherwise Specified - p. 56 7. 5 Myeloproliferative Neoplasms, Unclassifiable - p. 61 8. SECTION 2 Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions - p. 67 9. 6 Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions - p. 68 10. SECTION 3 Mastocytosis - p. 83 11. 7 Mastocytosis - p. 84 12. SECTION 4 Myelodysplastic/Myeloproliferative Neoplasms - p. 101 13. 8 Chronic Myelomonocytic Leukemia - p. 102 14. 9 Atypical Chronic Myeloid Leukemia - p. 110 15. 10 Myelodysplastic/Myeloproliferative Neoplasm With SF3B1 Mutation and Thrombocytosis - p. 114 16. 11 Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified - p. 118 17. SECTION 5 Premalignant Clonal Cytopenias and Myelodysplastic Syndromes - p. 123 18. Introduction to Premalignant Clonal Cytopenias and Myelodysplastic Syndromes - p. 124 19. 12 Clonal Cytopenia of Undetermined Significance and Other Clonal Cytopenias - p. 127 20. 13 Myelodysplastic Syndrome With Mutated SF3B1 - p. 132 21. 14 Myelodysplastic Syndrome With del(5q) - p. 136 22. 15 Myelodysplastic Syndrome With Mutated TP53 - p. 140 23. 16 Myelodysplastic Syndrome, Not Otherwise Specified - p. 145 24. 17 Myelodysplastic Syndrome With Excess Blasts - p. 150 25. 18 Myelodysplastic Syndrome/Acute Myeloid Leukemia - p. 153 26. SECTION 6 Pediatric and/or Germline Disorders - p. 159 27. 19 Juvenile Myelomonocytic Leukemia - p. 160 28. 20 Refractory Cytopenia of Childhood and Pediatric Myelodysplastic Syndromes - p. 166 29. 21 Hematologic Malignancies With Germline Predisposition - p. 171 30. SECTION 7 Acute Myeloid Leukemias - p. 189 31. 22 Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2)/PML::RARA and Acute Promyelocytic Leukemia With Other RARA Rearrangements - p. 190 32. 23 Acute Myeloid Leukemia With t(8;21)(q22;q22.1/RUNX1::RUNX1T1 - p. 194 33. 24 Acute Myeloid Leukemia With inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11 - p. 198 34. 25 Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3)/KMT2A::MLLT3 and Other KMT2A Rearrangements - p. 202 35. 26 Acute Myeloid Leukemia With t(6;9)(p22.3;q34.1)/DEK::NUP214 - p. 208 36. 27 Acute Myeloid Leukemia With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/GATA2; MECOM(EVI1) and Acute Myeloid Leukemia With Other MECOM Rearrangements - p. 211 37. 28 Acute Myeloid Leukemia With Other Rare Recurring Translocations - p. 215 38. 29 Acute Myeloid Leukemia With t(9;22)(q34.1;q11.2)/BCR::ABL1 - p. 218 39. 30 Acute Myeloid Leukemia With Mutated NPM1 - p. 221 40. 31 Acute Myeloid Leukemia With In-Frame bZIP CEBPA Mutations - p. 224 41. 32 Acute Myeloid Leukemia and Myelodysplastic Syndrome/Acute Myeloid Leukemia With Mutated TP53 - p. 228 42. 33 Acute Myeloid Leukemia and Myelodysplastic Syndrome/Acute Myeloid Leukemia With Myelodysplasia-Related Gene Mutations - p. 231 43. 34 Acute Myeloid Leukemia and Myelodysplastic Syndrome/Acute Myeloid Leukemia With Myelodysplasia-Related Cytogenetic Abnormalities - p. 234 44. 35 Acute Myeloid Leukemia and Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified - p. 237 45. 36 Myeloid Sarcoma - p. 245 46. SECTION 8 Myeloid Proliferations Associated With Down Syndrome - p. 249 47. 37 Myeloid Proliferations Associated With Down Syndrome - p. 250 48. SECTION 9 Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 255 49. 38 Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 256 50. SECTION 10 Lymphoblastic Neoplasms - p. 261 51. Introduction to Lymphoblastic Neoplasms - p. 262 52. 39 Acute Leukemias of Ambiguous Lineage - p. 275 53. 40 B-Lymphoblastic Leukemias/Lymphomas - p. 289 54. 41 T-Lymphoblastic Leukemias/Lymphomas - p. 315 55. 42 NK-Cell Acute Lymphoblastic Leukemia - p. 323 56. International Consensus Classification of Mature Lymphoid and Histiocytic/Dendritic Cell Neoplasms - p. 327 57. Introduction to the International Consensus Classification of Mature Lymphoid Neoplasms - p. 327 58. SECTION 11 Mature B-Cell Neoplasms - p. 339 59. 43 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Monoclonal B-Cell Lymphocytosis - p. 340 60. 44 B-Cell Prolymphocytic Leukemia - p. 348 61. 45 Splenic Marginal Zone Lymphoma - p. 351 62. 46 Hairy Cell Leukemia - p. 356 63. 47 Splenic B-Cell Lymphoma/Leukemia, Unclassifiable - p. 360 64. 48 Lymphoplasmacytic Lymphoma - p. 367 65. 49 IgM Monoclonal Gammopathy of Undetermined Significance - p. 373 66. 50 Primary Cold Agglutinin Disease - p. 375 67. 51 Heavy Chain Diseases - p. 377 68. 52 Plasma Cell Neoplasms - p. 384 69. 53 Monoclonal Immunoglobulin Deposition Diseases - p. 403 70. 54 Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) - p. 409 71. 55 Primary Cutaneous Marginal Zone Lymphoproliferative Disorder - p. 417 72. 56 Nodal Marginal Zone Lymphoma - p. 421 73. 57 Follicular Lymphoma - p. 427 74. 58 BCL2-Rearrangement Negative, CD23-Positive Follicle Center Lymphoma - p. 441 75. 59 Primary Cutaneous Follicle Center Lymphoma - p. 446 76. 60 Pediatric-Type Follicular Lymphoma - p. 450 77. 61 Testicular Follicular Lymphoma - p. 454 78. 62 Large B-Cell Lymphoma With IRF4 Rearrangement - p. 458 79. 63 Mantle Cell Lymphoma: Conventional and Leukemic Nonnodal Subtypes - p. 462 80. 64 Diffuse Large B-Cell Lymphoma, Not Otherwise Specified - p. 472 81. 65 Large B-Cell Lymphoma With 11q Aberration - p. 481 82. 66 Nodular Lymphocyte Predominant B-Cell Lymphoma - p. 484 83. 67 T-Cell/Histiocyte-Rich Large B-Cell Lymphoma - p. 490 84. 68 Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - p. 494 85. 69 Primary Diffuse Large B-Cell Lymphoma of the Testis - p. 499 86. 70 Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type - p. 502 87. 71 Intravascular Large B-Cell Lymphoma - p. 505 88. 72 HHV8- and EBV-Negative Primary Effusion-Based Lymphoma - p. 508 89. 73 Epstein-Barr Virus–Positive Mucocutaneous Ulcer - p. 510 90. 74 Epstein-Barr Virus–Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified - p. 514 91. 75 Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation - p. 518 92. 76 Lymphomatoid Granulomatosis - p. 523 93. 77 Epstein-Barr Virus–Positive Polymorphic B-Cell Lymphoproliferative Disorder, Not Otherwise Specified - p. 527 94. 78 ALK-Positive Large B-Cell Lymphoma - p. 532 95. 79 Plasmablastic Lymphoma - p. 535 96. 80 Human Herpesvirus 8–Associated Lymphoproliferative Disorders - p. 538 97. 81 Burkitt Lymphoma - p. 546 98. 82 High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements - p. 552 99. 83 High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements - p. 558 100. 84 High-Grade B-Cell Lymphoma, Not Otherwise Specified - p. 561 101. 85 Primary Mediastinal Large B-Cell Lymphoma - p. 564 102. 86 Mediastinal Gray Zone Lymphoma - p. 569 103. 87 Classic Hodgkin Lymphoma - p. 573 104. SECTION 12 Mature T- and NK-Cell Neoplasms - p. 587 105. 88 T-Cell Prolymphocytic Leukemia - p. 588 106. 89 T-Cell Large Granular Lymphocytic Leukemia - p. 594 107. 90 Chronic Lymphoproliferative Disorder of Natural Killer Cells - p. 600 108. 91 Adult T-Cell Leukemia/Lymphoma - p. 604 109. 92 Epstein-Barr Virus-Positive T- and Natural Killer-Cell Lymphoproliferative Disorders of Childhood - p. 613 110. 93 Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type - p. 627 111. 94 Aggressive Natural Killer-Cell Leukemia - p. 635 112. 95 Primary Nodal Epstein-Barr Virus-positive T-Cell/NK-Cell Lymphoma - p. 640 113. 96 Type II Refractory Celiac Disease and Enteropathy-Associated T-Cell Lymphoma - p. 644 114. 97 Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma - p. 655 115. 98 Intestinal T-Cell Lymphoma, Not Otherwise Specified and Indolent Lymphoproliferative Disorders of the Gastrointestinal Tract - p. 660 116. 99 Hepatosplenic T-Cell Lymphoma - p. 667 117. 100 Mycosis Fungoides - p. 672 118. 101 Sézary Syndrome - p. 680 119. 102 Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders - p. 684 120. 103 Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder - p. 695 121. 104 Subcutaneous Panniculitis-Like T-Cell Lymphoma - p. 697 122. 105 Primary Cutaneous Gamma-Delta T-Cell Lymphoma - p. 702 123. 106 Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder - p. 706 124. 107 Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma - p. 709 125. 108 Peripheral T-Cell Lymphoma, Not Otherwise Specified - p. 712 126. 109 Follicular Helper T-Cell Lymphoma - p. 720 127. 110 Anaplastic Large Cell Lymphoma, ALK Positive - p. 733 128. 111 Anaplastic Large Cell Lymphoma, ALK Negative - p. 741 129. 112 Breast Implant–Associated Anaplastic Large Cell Lymphoma - p. 749 130. SECTION 13 Immunodeficiency-Associated Lymphoproliferative Disorders - p. 753 131. 113 Posttransplant Lymphoproliferative Disorders - p. 754 132. 114 Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders - p. 769 133. SECTION 14 Histiocytic and Dendritic Cell Neoplasms - p. 777 134. 115 Histiocytic Sarcoma - p. 783 135. 116 Langerhans Cell Histiocytosis - p. 787 136. 117 Indeterminate Dendritic Cell Histiocytosis - p. 791 137. 118 Interdigitating Dendritic Cell Sarcoma - p. 794 138. 119 ALK-Positive Histiocytosis - p. 798 139. 120 Juvenile Xanthogranuloma - p. 803 140. 121 Erdheim-Chester Disease - p. 806 141. 122 Rosai-Dorfman-Destombes Disease - p. 811 142. 123 Follicular Dendritic Cell Sarcoma - p. 816 143. 124 Fibroblastic Reticular Cell Sarcoma - p. 820 144. 125 Epstein-Barr Virus–Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor - p. 822 145. Index - p. 825
No hay muestra disponible
No hay ficha técnica disponible
Developed by 149 experts in the field, The International Consensus Classification of Myeloid and Lymphoid Neoplasms provides key information for use at the microscope to assist in arriving at a swift and accurate diagnosis. Drs. Daniel Arber, Michael J. Borowitz, James Cook, Laurence de Leval, John Goodlad, Robert Hasserjian, Rebecca L. King, Hans-Michael Kvasnicka, and Attilio Orazi lead a team of authors who focus on diagnostic criteria and the clinical significance of each disease entity.
1. Introduction to the International Consensus Classification of Myeloid Disorders and Acute Leukemias - p. 1 2. SECTION 1 Myeloproliferative Neoplasms - p. 21 3. 1 Chronic Myeloid Leukemia - p. 22 4. 2 BCR::ABL1-Negative Myeloproliferative Neoplasms - p. 31 5. 3 Chronic Neutrophilic Leukemia - p. 52 6. 4 Chronic Eosinophilic Leukemia, Not Otherwise Specified - p. 56 7. 5 Myeloproliferative Neoplasms, Unclassifiable - p. 61 8. SECTION 2 Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions - p. 67 9. 6 Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions - p. 68 10. SECTION 3 Mastocytosis - p. 83 11. 7 Mastocytosis - p. 84 12. SECTION 4 Myelodysplastic/Myeloproliferative Neoplasms - p. 101 13. 8 Chronic Myelomonocytic Leukemia - p. 102 14. 9 Atypical Chronic Myeloid Leukemia - p. 110 15. 10 Myelodysplastic/Myeloproliferative Neoplasm With SF3B1 Mutation and Thrombocytosis - p. 114 16. 11 Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified - p. 118 17. SECTION 5 Premalignant Clonal Cytopenias and Myelodysplastic Syndromes - p. 123 18. Introduction to Premalignant Clonal Cytopenias and Myelodysplastic Syndromes - p. 124 19. 12 Clonal Cytopenia of Undetermined Significance and Other Clonal Cytopenias - p. 127 20. 13 Myelodysplastic Syndrome With Mutated SF3B1 - p. 132 21. 14 Myelodysplastic Syndrome With del(5q) - p. 136 22. 15 Myelodysplastic Syndrome With Mutated TP53 - p. 140 23. 16 Myelodysplastic Syndrome, Not Otherwise Specified - p. 145 24. 17 Myelodysplastic Syndrome With Excess Blasts - p. 150 25. 18 Myelodysplastic Syndrome/Acute Myeloid Leukemia - p. 153 26. SECTION 6 Pediatric and/or Germline Disorders - p. 159 27. 19 Juvenile Myelomonocytic Leukemia - p. 160 28. 20 Refractory Cytopenia of Childhood and Pediatric Myelodysplastic Syndromes - p. 166 29. 21 Hematologic Malignancies With Germline Predisposition - p. 171 30. SECTION 7 Acute Myeloid Leukemias - p. 189 31. 22 Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2)/PML::RARA and Acute Promyelocytic Leukemia With Other RARA Rearrangements - p. 190 32. 23 Acute Myeloid Leukemia With t(8;21)(q22;q22.1/RUNX1::RUNX1T1 - p. 194 33. 24 Acute Myeloid Leukemia With inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11 - p. 198 34. 25 Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3)/KMT2A::MLLT3 and Other KMT2A Rearrangements - p. 202 35. 26 Acute Myeloid Leukemia With t(6;9)(p22.3;q34.1)/DEK::NUP214 - p. 208 36. 27 Acute Myeloid Leukemia With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/GATA2; MECOM(EVI1) and Acute Myeloid Leukemia With Other MECOM Rearrangements - p. 211 37. 28 Acute Myeloid Leukemia With Other Rare Recurring Translocations - p. 215 38. 29 Acute Myeloid Leukemia With t(9;22)(q34.1;q11.2)/BCR::ABL1 - p. 218 39. 30 Acute Myeloid Leukemia With Mutated NPM1 - p. 221 40. 31 Acute Myeloid Leukemia With In-Frame bZIP CEBPA Mutations - p. 224 41. 32 Acute Myeloid Leukemia and Myelodysplastic Syndrome/Acute Myeloid Leukemia With Mutated TP53 - p. 228 42. 33 Acute Myeloid Leukemia and Myelodysplastic Syndrome/Acute Myeloid Leukemia With Myelodysplasia-Related Gene Mutations - p. 231 43. 34 Acute Myeloid Leukemia and Myelodysplastic Syndrome/Acute Myeloid Leukemia With Myelodysplasia-Related Cytogenetic Abnormalities - p. 234 44. 35 Acute Myeloid Leukemia and Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified - p. 237 45. 36 Myeloid Sarcoma - p. 245 46. SECTION 8 Myeloid Proliferations Associated With Down Syndrome - p. 249 47. 37 Myeloid Proliferations Associated With Down Syndrome - p. 250 48. SECTION 9 Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 255 49. 38 Blastic Plasmacytoid Dendritic Cell Neoplasm - p. 256 50. SECTION 10 Lymphoblastic Neoplasms - p. 261 51. Introduction to Lymphoblastic Neoplasms - p. 262 52. 39 Acute Leukemias of Ambiguous Lineage - p. 275 53. 40 B-Lymphoblastic Leukemias/Lymphomas - p. 289 54. 41 T-Lymphoblastic Leukemias/Lymphomas - p. 315 55. 42 NK-Cell Acute Lymphoblastic Leukemia - p. 323 56. International Consensus Classification of Mature Lymphoid and Histiocytic/Dendritic Cell Neoplasms - p. 327 57. Introduction to the International Consensus Classification of Mature Lymphoid Neoplasms - p. 327 58. SECTION 11 Mature B-Cell Neoplasms - p. 339 59. 43 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Monoclonal B-Cell Lymphocytosis - p. 340 60. 44 B-Cell Prolymphocytic Leukemia - p. 348 61. 45 Splenic Marginal Zone Lymphoma - p. 351 62. 46 Hairy Cell Leukemia - p. 356 63. 47 Splenic B-Cell Lymphoma/Leukemia, Unclassifiable - p. 360 64. 48 Lymphoplasmacytic Lymphoma - p. 367 65. 49 IgM Monoclonal Gammopathy of Undetermined Significance - p. 373 66. 50 Primary Cold Agglutinin Disease - p. 375 67. 51 Heavy Chain Diseases - p. 377 68. 52 Plasma Cell Neoplasms - p. 384 69. 53 Monoclonal Immunoglobulin Deposition Diseases - p. 403 70. 54 Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) - p. 409 71. 55 Primary Cutaneous Marginal Zone Lymphoproliferative Disorder - p. 417 72. 56 Nodal Marginal Zone Lymphoma - p. 421 73. 57 Follicular Lymphoma - p. 427 74. 58 BCL2-Rearrangement Negative, CD23-Positive Follicle Center Lymphoma - p. 441 75. 59 Primary Cutaneous Follicle Center Lymphoma - p. 446 76. 60 Pediatric-Type Follicular Lymphoma - p. 450 77. 61 Testicular Follicular Lymphoma - p. 454 78. 62 Large B-Cell Lymphoma With IRF4 Rearrangement - p. 458 79. 63 Mantle Cell Lymphoma: Conventional and Leukemic Nonnodal Subtypes - p. 462 80. 64 Diffuse Large B-Cell Lymphoma, Not Otherwise Specified - p. 472 81. 65 Large B-Cell Lymphoma With 11q Aberration - p. 481 82. 66 Nodular Lymphocyte Predominant B-Cell Lymphoma - p. 484 83. 67 T-Cell/Histiocyte-Rich Large B-Cell Lymphoma - p. 490 84. 68 Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - p. 494 85. 69 Primary Diffuse Large B-Cell Lymphoma of the Testis - p. 499 86. 70 Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type - p. 502 87. 71 Intravascular Large B-Cell Lymphoma - p. 505 88. 72 HHV8- and EBV-Negative Primary Effusion-Based Lymphoma - p. 508 89. 73 Epstein-Barr Virus–Positive Mucocutaneous Ulcer - p. 510 90. 74 Epstein-Barr Virus–Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified - p. 514 91. 75 Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation - p. 518 92. 76 Lymphomatoid Granulomatosis - p. 523 93. 77 Epstein-Barr Virus–Positive Polymorphic B-Cell Lymphoproliferative Disorder, Not Otherwise Specified - p. 527 94. 78 ALK-Positive Large B-Cell Lymphoma - p. 532 95. 79 Plasmablastic Lymphoma - p. 535 96. 80 Human Herpesvirus 8–Associated Lymphoproliferative Disorders - p. 538 97. 81 Burkitt Lymphoma - p. 546 98. 82 High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements - p. 552 99. 83 High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements - p. 558 100. 84 High-Grade B-Cell Lymphoma, Not Otherwise Specified - p. 561 101. 85 Primary Mediastinal Large B-Cell Lymphoma - p. 564 102. 86 Mediastinal Gray Zone Lymphoma - p. 569 103. 87 Classic Hodgkin Lymphoma - p. 573 104. SECTION 12 Mature T- and NK-Cell Neoplasms - p. 587 105. 88 T-Cell Prolymphocytic Leukemia - p. 588 106. 89 T-Cell Large Granular Lymphocytic Leukemia - p. 594 107. 90 Chronic Lymphoproliferative Disorder of Natural Killer Cells - p. 600 108. 91 Adult T-Cell Leukemia/Lymphoma - p. 604 109. 92 Epstein-Barr Virus-Positive T- and Natural Killer-Cell Lymphoproliferative Disorders of Childhood - p. 613 110. 93 Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type - p. 627 111. 94 Aggressive Natural Killer-Cell Leukemia - p. 635 112. 95 Primary Nodal Epstein-Barr Virus-positive T-Cell/NK-Cell Lymphoma - p. 640 113. 96 Type II Refractory Celiac Disease and Enteropathy-Associated T-Cell Lymphoma - p. 644 114. 97 Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma - p. 655 115. 98 Intestinal T-Cell Lymphoma, Not Otherwise Specified and Indolent Lymphoproliferative Disorders of the Gastrointestinal Tract - p. 660 116. 99 Hepatosplenic T-Cell Lymphoma - p. 667 117. 100 Mycosis Fungoides - p. 672 118. 101 Sézary Syndrome - p. 680 119. 102 Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders - p. 684 120. 103 Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder - p. 695 121. 104 Subcutaneous Panniculitis-Like T-Cell Lymphoma - p. 697 122. 105 Primary Cutaneous Gamma-Delta T-Cell Lymphoma - p. 702 123. 106 Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder - p. 706 124. 107 Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma - p. 709 125. 108 Peripheral T-Cell Lymphoma, Not Otherwise Specified - p. 712 126. 109 Follicular Helper T-Cell Lymphoma - p. 720 127. 110 Anaplastic Large Cell Lymphoma, ALK Positive - p. 733 128. 111 Anaplastic Large Cell Lymphoma, ALK Negative - p. 741 129. 112 Breast Implant–Associated Anaplastic Large Cell Lymphoma - p. 749 130. SECTION 13 Immunodeficiency-Associated Lymphoproliferative Disorders - p. 753 131. 113 Posttransplant Lymphoproliferative Disorders - p. 754 132. 114 Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders - p. 769 133. SECTION 14 Histiocytic and Dendritic Cell Neoplasms - p. 777 134. 115 Histiocytic Sarcoma - p. 783 135. 116 Langerhans Cell Histiocytosis - p. 787 136. 117 Indeterminate Dendritic Cell Histiocytosis - p. 791 137. 118 Interdigitating Dendritic Cell Sarcoma - p. 794 138. 119 ALK-Positive Histiocytosis - p. 798 139. 120 Juvenile Xanthogranuloma - p. 803 140. 121 Erdheim-Chester Disease - p. 806 141. 122 Rosai-Dorfman-Destombes Disease - p. 811 142. 123 Follicular Dendritic Cell Sarcoma - p. 816 143. 124 Fibroblastic Reticular Cell Sarcoma - p. 820 144. 125 Epstein-Barr Virus–Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor - p. 822 145. Index - p. 825
No hay muestra disponible
No hay ficha técnica disponible
